Clinical Trial Update: A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder [Phase 3]

View source ↗

Summary

A multinational Phase 3 trial evaluated long-term efficacy and safety of taking solifenacin succinate and mirabegron together versus each drug alone in adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Mirabegron (mirabegron)
• Solifenacin succinate (solifenacin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Urinary Bladder Overactive, Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2018-06-06